Published in J Vet Intern Med on July 28, 2010
Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapy. Sci Rep (2012) 1.07
B7-H3 is overexpressed in patients suffering osteosarcoma and associated with tumor aggressiveness and metastasis. PLoS One (2013) 1.05
Prognostic factors in canine appendicular osteosarcoma - a meta-analysis. BMC Vet Res (2012) 0.93
Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formation. J Clin Invest (2013) 0.92
A role for T-lymphocytes in human breast cancer and in canine mammary tumors. Biomed Res Int (2014) 0.85
Suppression of canine myeloid cells by soluble factors from cultured canine tumor cells. Vet Immunol Immunopathol (2011) 0.79
Genetically modified T-cell therapy for osteosarcoma. Adv Exp Med Biol (2014) 0.77
Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies. Oncoimmunology (2015) 0.75
The immunotherapy of canine osteosarcoma: a historical and systematic review. J Vet Intern Med (2015) 0.75
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol (2003) 38.57
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science (2006) 24.54
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med (2004) 22.96
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A (2005) 10.89
Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol (2006) 9.42
A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol (2005) 6.77
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J Clin Invest (2005) 5.30
Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients. Cancer Immunol Immunother (2006) 4.48
Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol (2004) 3.50
Foxp3 and natural regulatory T cells: key to a cell lineage? Immunity (2003) 3.29
Improving T cell therapy for cancer. Annu Rev Immunol (2007) 3.10
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer. Cancer Immunol Immunother (2008) 2.54
Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res (2009) 2.51
Feline immunodeficiency virus infection phenotypically and functionally activates immunosuppressive CD4+CD25+ T regulatory cells. J Immunol (2004) 1.39
Regulatory T cells and tumour immunity - observations in mice and men. Immunology (2007) 1.34
Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice. J Clin Invest (2009) 1.17
Regulatory cells and human cancer. Semin Cancer Biol (2005) 1.14
Positive and negative influences of regulatory T cells on tumour immunity. Oncogene (2008) 1.13
Dynamic behavior and function of Foxp3+ regulatory T cells in tumor bearing host. Cell Mol Immunol (2009) 1.13
CD4+CD25+ regulatory T cells are infected and activated during acute FIV infection. Vet Immunol Immunopathol (2008) 1.12
Regulatory T cells in health and disease. J Intern Med (2007) 1.12
Tumor regulatory T cells potently abrogate antitumor immunity. J Immunol (2009) 1.09
Use of alternating administration of carboplatin and doxorubicin in dogs with microscopic metastases after amputation for appendicular osteosarcoma: 50 cases (1999-2006). J Am Vet Med Assoc (2008) 1.04
Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck. J Cell Mol Med (2009) 1.02
Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer. Vet Immunol Immunopathol (2006) 0.97
A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25hiFoxP3+) in Ewing sarcoma patients is associated with metastatic disease. Int J Cancer (2009) 0.96
Detection of Foxp3 protein expression in porcine T lymphocytes. Vet Immunol Immunopathol (2008) 0.95
Lymphocyte subsets in peripheral blood of dogs--a flow cytometric study. Vet Immunol Immunopathol (2001) 0.89
Cloning of feline FOXP3 and detection of expression in CD4+CD25+ regulatory T cells. Vet Immunol Immunopathol (2007) 0.89
Differences in immune cells engaged in cell-mediated immunity after chemotherapy for far advanced pancreatic cancer. Pancreas (2006) 0.85
Changes in regulatory T cells in dogs with cancer and associations with tumor type. J Vet Intern Med (2009) 0.84
Effects of chemotherapy on immune responses in dogs with cancer. J Vet Intern Med (2006) 0.80
Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science (1999) 36.25
Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. Atherosclerosis (1995) 1.70
Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. J Virol (1994) 1.59
Football protective gear and cervical spine imaging. Ann Emerg Med (2001) 1.46
Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension. Circulation (2001) 1.43
Adrenocortical dysfunction following etomidate induction in emergency department patients. Acad Emerg Med (2001) 1.37
Fatal subclavian artery transection from isolated clavicle fracture. J Trauma (2000) 1.24
Intravenous etomidate for procedural sedation in emergency department patients. Acad Emerg Med (2001) 1.08
Metronomic therapy with cyclophosphamide and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcomas. J Vet Intern Med (2008) 0.99
Analysis of a feline immunodeficiency virus provirus reveals patterns of gene sequence conservation distinct from human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (1995) 0.98
Uptake of glycerol 3-phosphate and some of its analogs by the hexose phosphate transport system of Escherichia coli. J Bacteriol (1980) 0.98
Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer. Vet Immunol Immunopathol (2006) 0.97
Cell-specific envelope glycosylation distinguishes FIV glycoproteins produced in cytopathically and noncytopathically infected cells. Virology (1992) 0.94
Comparison of carboplatin and doxorubicin-based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma. J Vet Intern Med (2014) 0.93
A receptor presentation hypothesis for T cell help that recruits autoreactive B cells. J Immunol (2001) 0.93
Group B streptococcal infection in two cats. J Am Vet Med Assoc (1987) 0.92
Anaerobic bacterial infections and response to treatment in dogs and cats: 36 cases (1983-1985). J Am Vet Med Assoc (1986) 0.92
Intrathoracic stomach presenting as acute tension gastrothorax. Am J Emerg Med (1999) 0.90
Low-dose cyclophosphamide selectively decreases regulatory T cells and inhibits angiogenesis in dogs with soft tissue sarcoma. J Vet Intern Med (2011) 0.89
Development of monoclonal antibodies and capture immunoassays for feline immunodeficiency virus. Am J Vet Res (1995) 0.88
Phase II evaluation of VDC-1101 in canine cutaneous T-cell lymphoma. J Vet Intern Med (2014) 0.86
Inhaled heliox does not benefit ED patients with moderate to severe asthma. Am J Emerg Med (2000) 0.85
Extensive large colon resection in the pony. I. Surgical procedures and clinical results. Can J Vet Res (1987) 0.84
Changes in regulatory T cells in dogs with cancer and associations with tumor type. J Vet Intern Med (2009) 0.84
Somatotropin and insulin-like growth factor-I concentrations in plasma and milk after daily or sustained-release exogenous somatotropin administrations. Domest Anim Endocrinol (1994) 0.83
Liposome-DNA complexes infused intravenously inhibit tumor angiogenesis and elicit antitumor activity in dogs with soft tissue sarcoma. Cancer Gene Ther (2006) 0.83
A binding assay for 25-hydroxycalciferols and 24R,25-dihydroxycalciferols using bovine plasma globulin. Steroids (1977) 0.83
Significance of minimal or no intraperitoneal fluid visible on CT scan associated with blunt liver and splenic injuries: a multicenter analysis. J Trauma (2000) 0.83
Interleukins: biological properties and therapeutic potential. J Vet Intern Med (1992) 0.82
Bisphosphonates significantly increase the activity of doxorubicin or vincristine against canine malignant histiocytosis cells. Vet Comp Oncol (2011) 0.82
Nutrition of the weaned holstein calf. I. Effect of dietary protein level on rumen metabolism. J Anim Sci (1980) 0.82
Pulmonary thromboembolism associated with immune-mediated hemolytic anemia in dogs: ten cases (1982-1987). J Am Vet Med Assoc (1989) 0.82
Long-term evaluation of mesenchymal stem cell therapy in a feline model of chronic allergic asthma. Clin Exp Allergy (2014) 0.81
Increased monocyte chemotactic protein-1 concentration and monocyte count independently associate with a poor prognosis in dogs with lymphoma. Vet Comp Oncol (2010) 0.81
Lactation, health, and reproduction of dairy cows receiving daily injectable or sustained-release somatotropin. J Dairy Sci (1992) 0.81
Association of blood monocyte and lymphocyte count and disease-free interval in dogs with osteosarcoma. J Vet Intern Med (2010) 0.81
Extensive large colon resection in the pony. II. Digestibility studies and postmortem findings. Can J Vet Res (1987) 0.81
Secretion of interleukin-1 by bovine milk macrophages. Am J Vet Res (1991) 0.81
Specific insulin-like growth factor-I receptors on circulating bovine mononuclear cells. J Recept Res (1992) 0.81
Use of recombinant bovine somatotropin for up to two consecutive lactations on dairy production traits. J Dairy Sci (1990) 0.80
[Regression of mesenteric lymph node cavitation syndrome complicating celiac disease after a gluten free diet]. Gastroenterol Clin Biol (2000) 0.80
The free thoracodorsal artery perforator flap in head and neck reconstruction. Eur Ann Otorhinolaryngol Head Neck Dis (2012) 0.79
Variation in serum concentrations of immunoglobulins G, A, and M in Canadian Holstein-Friesian calves. J Dairy Sci (1989) 0.79
Anti-erythrocyte antibodies and disease associations in anemic and nonanemic dogs. J Vet Intern Med (2008) 0.79
Genetic parameters of bovine serum immunoglobulins. J Dairy Sci (1985) 0.79
Problems of child health in a Peruvian shanty town. Trop Doct (1976) 0.79
Bioactivity of milk from bST-treated cows. J Nutr (1990) 0.78
A hormonal assessment of bovine parturient paresis: evidence for a role of oestrogen. J Endocrinol (1981) 0.78
Elemental signatures of human diets from the Georgia Bight. Am J Phys Anthropol (1995) 0.78
Polymerase chain reaction for the detection of Toxoplasma gondii in aqueous humor of cats. Am J Vet Res (1996) 0.78
Health and reproductive performance of dairy cows treated for up to two consecutive lactations with bovine somatotropin. J Dairy Sci (1990) 0.78
Function of bovine mammary macrophages as antigen-presenting cells. Vet Immunol Immunopathol (1992) 0.78
Polymerase chain reaction for the detection of Toxoplasma gondii within aqueous humor of experimentally-inoculated cats. Vet Parasitol (1998) 0.78
Genetic immunotherapy for cancer. Semin Vet Med Surg (Small Anim) (1997) 0.77
Induction of remission results in spontaneous enhancement of anti-tumor cytotoxic T-lymphocyte activity in dogs with B cell lymphoma. Vet Immunol Immunopathol (2012) 0.77
Observations on intramammary infection and somatic cell counts in cows treated with recombinant bovine somatotropin. Can J Vet Res (1991) 0.77
Influence of exogenous bovine somatotropin on the responsiveness of peripheral blood lymphocytes to mitogen. J Dairy Sci (1991) 0.77
Induction of VEGF by tepoxalin does not lead to increased tumour growth in a canine osteosarcoma xenograft. Vet Comp Oncol (2010) 0.76
Elevated interleukin 6 activity in aqueous humor of cats with uveitis. Vet Immunol Immunopathol (1997) 0.76
Variation in serum immunoglobulins in Canadian Holstein-Friesians. J Dairy Sci (1983) 0.76
Higher Volume at Time of Breast Conserving Surgery Reduces Re-Excision in DCIS. Int J Surg Oncol (2011) 0.76
Etomidate. Acad Emerg Med (1995) 0.75
Examination of chemotactic properties of bovine mammary macrophages. Can J Vet Res (1991) 0.75
The effect of lipopolysaccharide on bovine mammary macrophage function. Can J Vet Res (1991) 0.75
Liposomal clodronate treatment for tumour macrophage depletion in dogs with soft-tissue sarcoma. Vet Comp Oncol (2012) 0.75
Hematological profiles in dairy cows treated with recombinant bovine somatotropin. J Anim Sci (1992) 0.75
Velopharyngeal function after free thoracodorsal artery perforator flap in lateral and superior oropharyngeal cancer. Eur Arch Otorhinolaryngol (2014) 0.75
Hypercalcemia associated with blastomycosis in dogs. J Am Vet Med Assoc (1986) 0.75
Contact sensitivity and systemic antibody responses in dairy cows treated with recombinant bovine somatotropin. J Dairy Sci (1992) 0.75
Interrelationships among energy input, body size, age and body composition of sheep. J Nutr (1969) 0.75
Feline leukemia virus infection downmodulates the production of growth-inhibitory activity by marrow stromal cells. Exp Hematol (1995) 0.75
Dinitrochlorobenzene contact hypersensitivity as a marker trait for selection to improve disease resistance in calves. J Dairy Sci (1989) 0.75
The effect of amniotic fluid ingestion on the nociception of cows. Physiol Behav (1997) 0.75
Effect of plane of nutrition before and after 200 kilograms of body weight on mammary development of prepubertal Holstein heifers. J Dairy Sci (1996) 0.75
Serum immunoglobulin profiles of dairy cows chronically treated with recombinant bovine somatotropin. J Dairy Sci (1991) 0.75
Muscle potassium content and potassium gluconate supplementation in normokalemic cats with naturally occurring chronic renal failure. J Vet Intern Med (1997) 0.75
Effects of insulin-like growth factor-I and its analogues on bovine hydrogen peroxide release by neutrophils and blastogenesis by mononuclear cells. J Endocrinol (1993) 0.75
Effect of protein on growth of Holstein heifer calves from 2 to 10 months. J Dairy Sci (1985) 0.75
Effects of dietary protein percentage and beta-agonist administered to prepubertal ewes on mammary gland growth and hormone secretions. J Anim Sci (1995) 0.75
Hypodipsic hypernatremia and associated myopathy in a hydrocephalic cat with transient hypopituitarism. J Am Vet Med Assoc (1987) 0.75
Anti-endothelial cell antibodies in dogs with immune-mediated hemolytic anemia and other diseases associated with high risk of thromboembolism. J Vet Intern Med (2009) 0.75
Effect of bovine somatotropin on the growth rate, hormone profiles and carcass composition of Holstein bull calves. Domest Anim Endocrinol (1990) 0.75
Continuous flumazenil infusion in the treatment of zolpidem (Ambien) and ethanol coingestion. J Toxicol Clin Toxicol (1998) 0.75
Metabolic and endocrine myopathies of dogs and cats. Semin Vet Med Surg (Small Anim) (1989) 0.75
Nutrition of the weaned holstein calf. II. Effect of dietary protein level on nitrogen balance, digestibility and feed intake. J Anim Sci (1980) 0.75
[Painful legs in a 45-year-old man]. Rev Med Interne (2010) 0.75
[A case report of Williams and Beuren syndrome with associated aggravation of in situ distal pulmonary vascular obstruction due to thrombotic disease]. Arch Mal Coeur Vaiss (2006) 0.75
[Intra-labyrinthine schwannomas: a report of two cases]. Ann Otolaryngol Chir Cervicofac (1998) 0.75
Ultrastructural changes in the uterine glands of the Roe deer during delayed implantation. J Physiol (1971) 0.75
[Acute pancreatitis in the puerperium. Diagnostic problems following cesarean section]. J Gynecol Obstet Biol Reprod (Paris) (1985) 0.75
Development of urethral occlusive techniques for restoration of urinary continence. Med Instrum (1977) 0.75
Evaluation of a biologic response modifier derived from Serratia marcescens: effects on feline macrophages and usefulness for the prevention and treatment of viremia in feline leukemia virus-infected cats. Mol Biother (1991) 0.75
Plasminogen activator production by bovine milk macrophages and blood monocytes. Am J Vet Res (1991) 0.75
[Radiofrequency treatment of lung tumours]. Rev Pneumol Clin (2011) 0.75
Antibody responses to human erythrocytes and ovalbumin as marker traits of disease resistance in dairy calves. J Dairy Sci (1989) 0.75
The effects of genetic and phenotypic production potential on response to recombinant bovine somatotropin. J Dairy Sci (1992) 0.75
Receptor binding and growth-promoting activity of insulin-like growth factor-I in a bovine mammary epithelial cell line (MAC-T3). J Endocrinol (1992) 0.75
Effect on production traits of bovine somatotropin for up to three consecutive lactations. J Dairy Sci (1992) 0.75
Effect of bovine skim milk and whey on monocyte function. J Dairy Sci (1991) 0.75
Response of bovine serum prolactin and growth hormone to duodenal, abomasal, and oral administration of thyrotropin-releasing hormone. J Dairy Sci (1977) 0.75